High-Dose Intravenous Immunoglobulin to Treat Cerebellar Degeneration

Clinical trial NCT00034242 · COMPLETED

Trial details

NCT number: NCT00034242
Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Spinocerebellar Degenerations

Start date: 2002-04-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.